Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2014

01-09-2014 | GRG Profiles and Perspectives

GRG Profiles: Professor Ignazio Marino

Author: Ignazio R. Marino

Published in: Digestive Diseases and Sciences | Issue 9/2014

Login to get access

Excerpt

Ignazio Marino was born in Genoa, Italy, in 1955 as the son of a naval engineer. His interest in medicine, in particular surgery, began while attending high school as a mean to “achieve tangible results and life-changing outcomes on patients, by mastering what then appeared to [him] as an exact science and a clear scientific method.” At age 12, Ignazio heard about the first heart transplant operation, performed by Christiaan Barnard in Cape Town in 1967, which reinforced his interest. …
Literature
1.
Marino IR, De Luca G. Orthotopic liver transplantation in pigs: an evaluation of different methods to avoid the revascularization syndrome. Transplantation. 1985;40:494–498.PubMedCrossRef
2.
3.
Weber T, Marino IR, Kang YG, Esquivel CO, Starzl TE, Duquesnoy RJ. Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation. 1989;47:797–801.PubMedCentralPubMedCrossRef
4.
5.
Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995;22:1754–1762.PubMedCentralPubMed
6.
Singh N, Gayowski T, Wannstedt CF, et al. Interferon-α for prophylaxis of recurrent viral hepatitis C virus in liver transplant recipients. A prospective, randomized, controlled trial. Transplantation. 1998;65:82–86.PubMedCrossRef
7.
Singh N, Gayowski T, Marino IR. Causes of leukocytosis in liver transplant recipients. Relevance in clinical practice. Transplantation. 1998;65:199–203.PubMedCrossRef
8.
Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007;211:27–37.PubMedCrossRef
Metadata
Title
GRG Profiles: Professor Ignazio Marino
Author
Ignazio R. Marino
Publication date
01-09-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3301-5

Other articles of this Issue 9/2014

Digestive Diseases and Sciences 9/2014 Go to the issue

Original Article

Efficacy of Transjugular Intrahepatic Portosystemic Shunt with Adjunctive Embolotherapy with Cyanoacrylate for Esophageal Variceal Bleeding

Case Report

Bleeding Gastroesophageal Varices: What the Umbo Embo Can Do for You

Editorial

Reducing Racial Disparity in Colorectal Cancer Burden

Editorial

Ischemia–Reperfusion Injury and Regrowth of Liver Cancers: To Clamp or Not to Clamp?

Original Article

A Novel Adenosine Precursor 2′,3′-Cyclic Adenosine Monophosphate Inhibits Formation of Post-surgical Adhesions

Original Article

Antitumor Efficacy of CC Motif Chemokine Ligand 19 in Colorectal Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits